Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions with
shared risk factors. The growing prevalence of both AF and CKD indicates that more patients …

Background—We sought to define the factors associated with the occurrence of stroke and
systemic embolism in a large, international atrial fibrillation (AF) trial. Methods and Results …

Purpose Although direct oral anticoagulants (DOACs) are associated with an overall
favourable safety profile, the risk of gastrointestinal bleeding with DOACs compared with …

Soft carbon features low-cost and high-carbon-yield advantages but possesses highly
graphitized structures at high pyrolysis temperatures, limiting its application as anode for the …

Aims Diversified cardiovascular/non-cardiovascular multi-morbid risk and efficient machine
learning algorithms may facilitate improvements in stroke risk prediction, especially in newly …

Background and objectives: COVID-19 is associated with an aberrant inflammatory
response that may trigger new-onset cardiac arrhythmias. The aim of this study was to …

AF contributes to increased stroke risk via various mechanisms, including deranged blood
constituents, vessel wall abnormalities and abnormal blood flow. This excess risk is …

Aims The net benefit of oral anticoagulants (OACs) in atrial fibrillation (AF) is poorly
understood. We aimed to determine the NNT for net effect (NNTnet) using calculator of …

Background: Mechanisms by which chronic kidney disease (CKD) influences fibrin clot
properties in atrial fibrillation (AF) remain ill-defined. We aimed to investigate the effects of …

Background: Despite its benefits, oral anticoagulant (OAC) therapy in patients with atrial
fibrillation (AF) is associated with hemorrhagic complication s. Aims: We aimed to evaluate …